help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, M. M.
Right arrow Articles by MacLaughlin, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, M. M.
Right arrow Articles by MacLaughlin, D. T.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 571-576, Copyright © 1996 by Endocrine Society

ARTICLES

Mullerian inhibiting substance in humans: normal levels from infancy to adulthood

MM Lee, PK Donahoe, T Hasegawa, B Silverman, GB Crist, S Best, Y Hasegawa, RA Noto, D Schoenfeld and DT MacLaughlin
Pediatric Endocrine Unit, Massachusetts General Hospital, Boston 02114, USA.

Mullerian-inhibiting substance (MIS) is a gonadal hormone synthesized by Sertoli cells of the testis and granulosa cells of the ovary. To facilitate the use of MIS for the evaluation of intersex disorders and as a tumor marker in women with MIS-expressing ovarian tumors, we measured MIS in 600 serum samples from males and females. These data show that mean MIS values for males rise rapidly during the first year of life and are highest during late infancy, then gradually decline until puberty. In contrast, MIS values in females are lowest at birth and exhibit a minimal increase throughout the prepubertal years. Whereas MIS is uniformly measurable in all prepubertal boys studied, it is undetectable in most prepubertal female subjects. These data reveal an easily discernible sexually dimorphic pattern of expression and confirm that MIS can be used as a testis-specific marker during infancy and early childhood. MIS values that are above the upper limits for females are discriminatory for the presence of testicular tissue or ovarian tumor, and those below the lower limits for males are consistent with dysgenetic or absent testes or the presence of ovarian tissue. These data will enable normal and abnormal levels of MIS to be differentiated with higher precision and will facilitate the use of MIS in the management of gonadal disorders.


This article has been cited by other articles:


Home page
 Hum ReprodHome page
A.A. Sinisi, D. Esposito, L. Maione, M.C. Quinto, D. Visconti, A. De Bellis, A. Bellastella, G. Conzo, and G. Bellastella
Seminal anti-Mullerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism
Hum. Reprod., May 1, 2008; 23(5): 1029 - 1034.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Crisosto, E. Codner, M. Maliqueo, B. Echiburu, F. Sanchez, F. Cassorla, and T. Sir-Petermann
Anti-Mullerian Hormone Levels in Peripubertal Daughters of Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2739 - 2743.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
A. L. Marca and A. Volpe
The Anti-Mullerian hormone and ovarian cancer
Hum. Reprod. Update, May 1, 2007; 13(3): 265 - 273.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
D. B. Seifer, D. T. MacLaughlin, and H. S. Cuckle
Serum mullerian-inhibiting substance in Down's syndrome pregnancies
Hum. Reprod., April 1, 2007; 22(4): 1017 - 1020.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. La Marca, S. Giulini, A. Tirelli, E. Bertucci, T. Marsella, S. Xella, and A. Volpe
Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology
Hum. Reprod., March 1, 2007; 22(3): 766 - 771.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Sanchez, P. Alama, B. Gadea, S.R. Soares, C. Simon, and A. Pellicer
Fresh human orthotopic ovarian cortex transplantation: long-term results
Hum. Reprod., March 1, 2007; 22(3): 786 - 791.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. La Marca, G. Stabile, A.C. Artenisio, and A. Volpe
Serum anti-Mullerian hormone throughout the human menstrual cycle
Hum. Reprod., December 1, 2006; 21(12): 3103 - 3107.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
K. M Main, J. Toppari, and N. E Skakkebaek
Gonadal development and reproductive hormones in infant boys
Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S51 - S57.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
T. T. Tran, D. L. Segev, V. Gupta, H. Kawakubo, G. Yeo, P. K. Donahoe, and S. Maheswaran
Mullerian Inhibiting Substance Regulates Androgen-Induced Gene Expression and Growth in Prostate Cancer Cells through a Nuclear Factor-{kappa}B-Dependent Smad-Independent Mechanism
Mol. Endocrinol., October 1, 2006; 20(10): 2382 - 2391.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
W. J. K. Hehenkamp, C. W. N. Looman, A. P. N. Themmen, F. H. de Jong, E. R. te Velde, and F. J. M. Broekmans
Anti-Mullerian Hormone Levels in the Spontaneous Menstrual Cycle Do Not Show Substantial Fluctuation
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4057 - 4063.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
I. Bergada, C. Milani, P. Bedecarras, L. Andreone, M. G. Ropelato, S. Gottlieb, C. Bergada, S. Campo, and R. A. Rey
Time Course of the Serum Gonadotropin Surge, Inhibins, and Anti-Mullerian Hormone in Normal Newborn Males during the First Month of Life
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4092 - 4098.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser
The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
Endocr. Rev., April 1, 2006; 27(2): 170 - 207.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
J. A Visser, F. H de Jong, J. S E Laven, and A. P N Themmen
Anti-Mullerian hormone: a new marker for ovarian function
Reproduction, January 1, 2006; 131(1): 1 - 9.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
T. Silberstein, D.T. MacLaughlin, I. Shai, J.R. Trimarchi, G. Lambert-Messerlian, D.B. Seifer, D.L. Keefe, and A.S. Blazar
Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology
Hum. Reprod., January 1, 2006; 21(1): 159 - 163.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P.-Y. Wang, K. Koishi, A. B. McGeachie, M. Kimber, D. T. MacLaughlin, P. K. Donahoe, and I. S. McLennan
Mullerian Inhibiting Substance acts as a motor neuron survival factor in vitro
PNAS, November 8, 2005; 102(45): 16421 - 16425.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J. Penarrubia, F. Fabregues, D. Manau, M. Creus, G. Casals, R. Casamitjana, F. Carmona, J. A. Vanrell, and J. Balasch
Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment
Hum. Reprod., April 1, 2005; 20(4): 915 - 922.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. Gupta, J. L. Carey, H. Kawakubo, A. Muzikansky, J. E. Green, P. K. Donahoe, D. T. MacLaughlin, and S. Maheswaran
Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model
PNAS, March 1, 2005; 102(9): 3219 - 3224.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
X. Wu, R. Arumugam, S. P. Baker, and M. M. Lee
Pubertal and Adult Leydig Cell Function in Mullerian Inhibiting Substance-Deficient Mice
Endocrinology, February 1, 2005; 146(2): 589 - 595.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. J. Renaud, D. T. MacLaughlin, E. Oliva, B. R. Rueda, and P. K. Donahoe
Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance
PNAS, January 4, 2005; 102(1): 111 - 116.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. La Marca, S. Malmusi, S. Giulini, L. F. Tamaro, R. Orvieto, P. Levratti, and A. Volpe
Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation
Hum. Reprod., December 1, 2004; 19(12): 2738 - 2741.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. G.M.G.J. Mulders, J. S.E. Laven, M. J.C. Eijkemans, F. H. de Jong, A. P.N. Themmen, and B. C.J.M. Fauser
Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility
Hum. Reprod., September 1, 2004; 19(9): 2036 - 2042.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. L. Britt, P. G. Stanton, M. Misso, E. R. Simpson, and J. K. Findlay
The Effects of Estrogen on the Expression of Genes Underlying the Differentiation of Somatic Cells in the Murine Gonad
Endocrinology, August 1, 2004; 145(8): 3950 - 3960.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. M. Wikstrom, T. Raivio, F. Hadziselimovic, S. Wikstrom, T. Tuuri, and L. Dunkel
Klinefelter Syndrome in Adolescence: Onset of Puberty Is Associated with Accelerated Germ Cell Depletion
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2263 - 2270.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
D. T. MacLaughlin and P. K. Donahoe
Sex Determination and Differentiation
N. Engl. J. Med., January 22, 2004; 350(4): 367 - 378.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Misra, D. T. MacLaughlin, P. K. Donahoe, and M. M. Lee
The Role of Mullerian Inhibiting Substance in the Evaluation of Phenotypic Female Patients with Mild Degrees of Virilization
J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 787 - 792.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
V. M. Laurich, A. M. Trbovich, F. H. O'Neill, C. P. Houk, P. M. Sluss, A. H. Payne, P. K. Donahoe, and J. Teixeira
Mullerian Inhibiting Substance Blocks the Protein Kinase A-Induced Expression of Cytochrome P450 17{alpha}-Hydroxylase/C17-20 Lyase mRNA in a Mouse Leydig Cell Line Independent of cAMP Responsive Element Binding Protein Phosphorylation
Endocrinology, September 1, 2002; 143(9): 3351 - 3360.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Misra, D. T. MacLaughlin, P. K. Donahoe, and M. M. Lee
Measurement of Mullerian Inhibiting Substance Facilitates Management of Boys with Microphallus and Cryptorchidism
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3598 - 3602.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. E. Stephen, L. A. Pearsall, B. P. Christian, P. K. Donahoe, J. P. Vacanti, and D. T. MacLaughlin
Highly Purified Mullerian Inhibiting Substance Inhibits Human Ovarian Cancer in Vivo
Clin. Cancer Res., August 1, 2002; 8(8): 2640 - 2646.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Fujisawa, T. Yamasaki, H. Okada, and S. Kamidono
The significance of anti-Mullerian hormone concentration in seminal plasma for spermatogenesis
Hum. Reprod., April 1, 2002; 17(4): 968 - 970.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Pitteloud, F. J. Hayes, P. A. Boepple, S. DeCruz, S. B. Seminara, D. T. MacLaughlin, and W. F. Crowley Jr.
The Role of Prior Pubertal Development, Biochemical Markers of Testicular Maturation, and Genetics in Elucidating the Phenotypic Heterogeneity of Idiopathic Hypogonadotropic Hypogonadism
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 152 - 160.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. Teixeira, S. Maheswaran, and P. K. Donahoe
Mullerian Inhibiting Substance: An Instructive Developmental Hormone with Diagnostic and Possible Therapeutic Applications
Endocr. Rev., October 1, 2001; 22(5): 657 - 674.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
E. J. Richmond, C. J. Flickinger, J. A. McDonald, M. A. Lovell, and A. D. Rogol
Lipoid Congenital Adrenal Hyperplasia (CAH): Patient Report and a Mini-Review
Clinical Pediatrics, July 1, 2001; 40(7): 403 - 407.
[PDF]

Home page
 Biol. Reprod.Home page
J. J. Tremblay and R. S. Viger
Nuclear Receptor Dax-1 Represses the Transcriptional Cooperation Between GATA-4 and SF-1 in Sertoli Cells
Biol Reprod, April 1, 2001; 64(4): 1191 - 1199.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. M. Trbovich, P. M. Sluss, V. M. Laurich, F. H. O'Neill, D. T. MacLaughlin, P. K. Donahoe, and J. Teixeira
Mullerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents
PNAS, March 1, 2001; (2001) 51632298.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
W.-Q. Long, V. Ranchin, P. Pautier, C. Belville, P. Denizot, H. Cailla, C. Lhommé, J.-Y. Picard, J.-M. Bidart, and R. Rey
Detection of Minimal Levels of Serum Anti-Mullerian Hormone during Follow-Up of Patients with Ovarian Granulosa Cell Tumor by Means of a Highly Sensitive Enzyme-Linked Immunosorbent Assay
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 540 - 544.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. W. Speiser, M. Susin, H. Sasano, S. Bohrer, and J. Markowitz
Ovarian Hyperthecosis in the Setting of Portal Hypertension
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 873 - 877.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
P. T. Masiakos, D. T. MacLaughlin, S. Maheswaran, J. Teixeira, A. F. Fuller Jr., P. C. Shah, D. J. Kehas, M. K. Kenneally, D. M. Dombkowski, T. U. Ha, et al.
Human Ovarian Cancer, Cell Lines, and Primary Ascites Cells Express the Human Mullerian Inhibiting Substance (MIS) Type II Receptor, Bind, and Are Responsive to MIS
Clin. Cancer Res., November 1, 1999; 5(11): 3488 - 3499.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Rajpert-De Meyts, N. Jorgensen, N. Gram, J. Muller, R. L. Cate, and N. E. Skakkebak
Expression of Anti-Mullerian Hormone during Normal and Pathological Gonadal Development: Association with Differentiation of Sertoli and Granulosa Cells
J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3836 - 3844.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Teixeira, E. Fynn-Thompson, A. H. Payne, and P. K. Donahoe
Mullerian-Inhibiting Substance Regulates Androgen Synthesis at the Transcriptional Level
Endocrinology, October 1, 1999; 140(10): 4732 - 4738.
[Abstract] [Full Text]

Home page
 Hum ReprodHome page
P. Fenichel, R. Rey, S. Poggioli, M. Donzeau, D. Chevallier, and G. Pointis
Anti-Mullerian hormone as a seminal marker for spermatogenesis in non-obstructive azoospermia
Hum. Reprod., August 1, 1999; 14(8): 2020 - 2024.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. A. Rey, C. Belville, C. Nihoul-Fékété, L. Michel-Calemard, M. G. Forest, N. Lahlou, F. Jaubert, I. Mowszowicz, M. David, N. Saka, et al.
Evaluation of Gonadal Function in 107 Intersex Patients by Means of Serum Antimullerian Hormone Measurement
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 627 - 631.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
W. Byrd, M. J. Bennett, B. R. Carr, Y. Dong, F. Wians, and W. Rainey
Regulation of Biologically Active Dimeric Inhibin A and B From Infancy to Adulthood in the Male
J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2849 - 2854.
[Abstract] [Full Text]

Home page
 NEJMHome page
M. M. Lee, P. K. Donahoe, B. L. Silverman, T. Hasegawa, Y. Hasegawa, M. L. Gustafson, Y. Chang, and D. T. MacLaughlin
Measurements of Serum Mullerian Inhibiting Substance in the Evaluation of Children with Nonpalpable Gonads
N. Engl. J. Med., May 22, 1997; 336(21): 1480 - 1486.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
E. A. Catlin, V. C. Tonnu, R. G. Ebb, B. A. Pacheco, T. F. Manganaro, R. M. Ezzell, P. K. Donahoe, and J. Teixeira
Mullerian Inhibiting Substance Inhibits Branching Morphogenesis and Induces Apoptosis in Fetal Rat Lung
Endocrinology, February 1, 1997; 138(2): 790 - 796.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. L. Segev, T. U. Ha, T. T. Tran, M. Kenneally, P. Harkin, M. Jung, D. T. MacLaughlin, P. K. Donahoe, and S. Maheswaran
Mullerian Inhibiting Substance Inhibits Breast Cancer Cell Growth through an NFkappa B-mediated Pathway
J. Biol. Chem., September 8, 2000; 275(37): 28371 - 28379.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. U. Ha, D. L. Segev, D. Barbie, P. T. Masiakos, T. T. Tran, D. Dombkowski, M. Glander, T. R. Clarke, H. K. Lorenzo, P. K. Donahoe, et al.
Mullerian Inhibiting Substance Inhibits Ovarian Cell Growth through an Rb-independent Mechanism
J. Biol. Chem., November 17, 2000; 275(47): 37101 - 37109.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. L. Segev, Y. Hoshiya, A. E. Stephen, M. Hoshiya, T. T. Tran, D. T. MacLaughlin, P. K. Donahoe, and S. Maheswaran
Mullerian Inhibiting Substance Regulates NFkappa B Signaling and Growth of Mammary Epithelial Cells in Vivo
J. Biol. Chem., July 13, 2001; 276(29): 26799 - 26806.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. M. Trbovich, P. M. Sluss, V. M. Laurich, F. H. O'Neill, D. T. MacLaughlin, P. K. Donahoe, and J. Teixeira
Mullerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents
PNAS, March 13, 2001; 98(6): 3393 - 3397.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society